Dr RENUGA DEVI. V,Dr VIJAY YASWANTH REDDY BADE,Dr. N. GUNASEKARAN,Dr PRIYADARSHINI VARADARAJ,DR. M. ABHINAYA
DOI: https://doi.org/Background: Functional iron deficiency anaemia (FIDA), which can worsen HF symptoms and raise morbidity and mortality, is a common complicating factor for heart failure (HF). It has been suggested that intravenous (IV) iron supplementation be used as a treatment intervention to help these people do better. Methods: In 200 patients with FIDA-diagnosed heart failure, the effects of IV iron supplementation on mortality and morbidity were examined in this study. Over the course of two years, a single tertiary care facility hosted a randomised controlled experiment. Results: Preliminary results indicate a significant reduction in hospital readmission rates and improvements in quality of life scores among patients receiving IV iron supplementation compared to those receiving standard care. Conclusion: IV iron supplementation in HF patients with FIDA appears to significantly improve clinical outcomes and reduce healthcare utilization. Further research is warranted to confirm these findings and determine optimal management strategies.
